obesity drug news today october 21 2025 glp-1 therapies are changing care. What does WHO recommend? , Here’s what you need to know Patients seeking cheaper weight-loss drugs

It was first approved as Egrifta in November 2010 for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy, and it remains a prescription drug with a regulator-reviewed label, including a defined dose, defined contraindications, and required safety monitoring

Have a B12-rich food like steak, and your serum level can rise to more than 1500 pg/mL for a short time

Because of this, its effectiveness can vary depending on the tirzepatide compounding pharmacy and how it's made

Patients with dementia had significant cognitive decline, which resulted in interference with independence in daily functioning